|
|
???tair.name??? >
???browser.page.title.author???
|
"yau thomas"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-10-21T23:28:16Z |
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
|
Dai, Ming Shen; Feng, Yin Hsun; Chen, Shang Wen; Masuda, Norikazu; Yau, Thomas; Chen, Shou Tung; YEN-SHEN LU; Yap, Yoon Sim; Ang, Peter C.S.; Chu, Sung Chao; Kwong, Ava; Lee, Keun Seok; Ow, Samuel; Kim, Sung Bae; Lin, Johnson; Chung, Hyun Cheol; Ngan, Roger; Kok, Victor C.; Rau, Kun Ming; Sangai, Takafumi; Ng, Ting Ying; Tseng, Ling Ming; Bryce, Richard; Bebchuk, Judith; Chen, Mei Chieh; Hou, Ming Feng |
| 國立成功大學 |
2016-10 |
Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC)
|
Llovet, Josep M.;Merle, Philippe;Weiss, Karl Heinz;Yau, Thomas;Ross, Paul;Mazzaferro, Vincenzo;Blanc, Jean-Frederic;Ma, Yuk T.;Yen, Chia Jui;Kocsis, Judit;Choo, Su Pin;Sukeepaisarnjaroen, Watana;Gerolami, Rene;Dufour, Jean -Francois;Gane, Edward J.;Ryoo, Baek-Yeol;Peck-Radosavljevic, Markus;Dao, Thong;Yeo, Winnie;Lamlertthon, Wisut;Thongsawat, Satawat;Teufel, Michael;Krissel, Heiko;Lim, Ho Yeong |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
